Cetera Trust Company N.A bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,023 shares of the company’s stock, valued at approximately $1,179,000.
Several other institutional investors have also added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in shares of HCA Healthcare during the second quarter valued at about $5,069,974,000. Norges Bank bought a new stake in HCA Healthcare during the 4th quarter valued at approximately $1,262,513,000. Life Cycle Investment Partners Ltd bought a new position in shares of HCA Healthcare in the 4th quarter worth approximately $374,037,000. Viking Global Investors LP boosted its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after purchasing an additional 649,058 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Robert W. Baird reduced their target price on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a research report on Monday, July 27th. Royal Bank Of Canada restated an “outperform” rating and issued a $435.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Stephens lowered their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Finally, Mizuho reduced their price target on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a report on Tuesday, July 28th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $462.64.
HCA Healthcare Stock Down 0.0%
Shares of NYSE HCA opened at $429.19 on Tuesday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a 50 day moving average of $397.94 and a 200 day moving average of $443.28. The firm has a market cap of $92.92 billion, a P/E ratio of 14.37, a PEG ratio of 1.49 and a beta of 1.10.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the prior year, the company posted $6.84 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, equities analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is presently 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
